Literature DB >> 22484822

Pharmacologic cardiac resynchronization of a 1-year-old boy with severe left ventricular dysfunction.

Christian Paech1, Patrick Flosdorff, Roman Antonin Gebauer.   

Abstract

Postero-septal accessory pathways (AP) are a rare cause of intraventricular dyssynchrony and severe LV dysfunction in children. Beside the common treatment with radiofrequency ablation of septal substrates we present the case of a successful pharmacologic resynchronization in a 13/12 years old male toddler with Wolff-Parkinson-White syndrome (WPW) and severe LV dysfunction (left ventricular biplane EF of 31 %) due to intraventricular dyssynchrony with septal to posterior wall motion delay (SPWMD) of 350 ms. Interventricular mechanical delay (IVMD) was 65 ms. Using propafenone, pharmacologic cardiac resynchronization could be achieved. Pharmacologic resynchronization should be considered as safe and effective alternative to catheter ablation in very young children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484822     DOI: 10.1007/s00246-012-0310-z

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  4 in total

Review 1.  NASPE Expert Consensus Conference: Radiofrequency catheter ablation in children with and without congenital heart disease. Report of the writing committee. North American Society of Pacing and Electrophysiology.

Authors:  Richard A Friedman; Edward P Walsh; Michael J Silka; Hugh Calkins; William G Stevenson; Larry A Rhodes; Barbara J Deal; Grace S Wolff; David R Demaso; Debra Hanisch; George F Van Hare
Journal:  Pacing Clin Electrophysiol       Date:  2002-06       Impact factor: 1.976

2.  Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists.

Authors:  J Janousek; T Paul
Journal:  Am J Cardiol       Date:  1998-05-01       Impact factor: 2.778

Review 3.  New antiarrhythmic drugs in pediatric use: propafenone.

Authors:  T Paul; J Janousek
Journal:  Pediatr Cardiol       Date:  1994 Jul-Aug       Impact factor: 1.655

4.  Adverse effects of Wolff-Parkinson-White syndrome with right septal or posteroseptal accessory pathways on cardiac function.

Authors:  Maren Tomaske; Jan Janousek; Vít Rázek; Roman A Gebauer; Viktor Tomek; Gerd Hindricks; Walter Knirsch; Urs Bauersfeld
Journal:  Europace       Date:  2008-02       Impact factor: 5.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.